Head to Head Survey: SONOVA HLDG AG/ADR (SONVY) vs. NxStage Medical (NXTM)

NxStage Medical (NASDAQ:NXTM) and SONOVA HLDG AG/ADR (OTCMKTS:SONVY) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Dividends

SONOVA HLDG AG/ADR pays an annual dividend of $0.30 per share and has a dividend yield of 0.7%. NxStage Medical does not pay a dividend. SONOVA HLDG AG/ADR pays out 22.9% of its earnings in the form of a dividend.

Volatility and Risk

NxStage Medical has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, SONOVA HLDG AG/ADR has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500.

Profitability

This table compares NxStage Medical and SONOVA HLDG AG/ADR’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NxStage Medical -1.29% -2.50% -1.60%
SONOVA HLDG AG/ADR N/A N/A N/A

Earnings and Valuation

This table compares NxStage Medical and SONOVA HLDG AG/ADR’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NxStage Medical $393.94 million 5.08 -$14.47 million ($0.22) -136.36
SONOVA HLDG AG/ADR $2.73 billion 4.84 $412.45 million $1.31 30.82

SONOVA HLDG AG/ADR has higher revenue and earnings than NxStage Medical. NxStage Medical is trading at a lower price-to-earnings ratio than SONOVA HLDG AG/ADR, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings for NxStage Medical and SONOVA HLDG AG/ADR, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NxStage Medical 0 0 0 0 N/A
SONOVA HLDG AG/ADR 0 0 1 0 3.00

Insider and Institutional Ownership

80.3% of NxStage Medical shares are held by institutional investors. 4.9% of NxStage Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

SONOVA HLDG AG/ADR beats NxStage Medical on 10 of the 14 factors compared between the two stocks.

About NxStage Medical

NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

About SONOVA HLDG AG/ADR

Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological care services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand; and professional hearing care services under the AudioNova, Audium, AuditionSanté, Boots Hearingcare, Connect Hearing, Fiebing, Geers, Hansaton, Lapperre, Lindacher, Schoonenberg, Triton, and Vitakustik brands. Sonova Holding operates through sales channels, including independent healthcare professionals, government agencies, clinics, and retail network, as well as through Sonova-owned wholesale companies and independent distributors. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.